Alternative Lengthening of Telomeres in Cancer Confers a Vulnerability to Reactivation of p53 Function

Abstract excerpt

A subset of cancers across multiple histologies with predominantly poor outcomes use the alternative lengthening of telomeres (ALT) mechanism to maintain telomere length, which can be identified with robust biomarkers. ALT has been reported to be prevalent in high-risk neuroblastoma and certain sarcomas, and ALT cancers are a major clinical challenge that lack targeted therapeutic approaches. Here, we found ALT...

Topics

Share this publication in a Topic to start or enrich a Post.

• Share to DNA Repair Mechanisms
• Share to Microtubule and mitosis dynamics
• Share to Telomeres, Telomerase, and Senescence